Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03188965
Title First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bayer

diffuse large B-cell lymphoma

colorectal cancer

endometrial cancer

prostate cancer

non-Hodgkin lymphoma

ovarian cancer

cervical cancer

mantle cell lymphoma

lung cancer

Advanced Solid Tumor



Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST